This company offers facile technology for separating nanoparticle mixtures prior to detection, enabling true size distribution analysis even for polydispersed samples. Their process quickly separates and sizes various nanoparticles, including lipid nanoparticles, liposomes, and viruses, within minutes per sample. This capability supports the accurate measurement, impurity separation, and aggregation detection necessary for advancing nanomedicine applications.
Funding
Funding not disclosed
Founders
Product
Problem
Accurate characterization of nanoparticle size distribution, particularly for polydispersed samples, is critical for the development of effective nanomedicines. Existing methods often lack the precision or speed required for comprehensive analysis of complex mixtures, hindering the development of novel therapeutics.
Solution
Imessa Research provides a facile technology platform for the separation and sizing of nanoparticle mixtures, delivering precise size distribution data for polydispersed samples. This system is capable of analyzing a range of nanoparticles, including lipid nanoparticles, liposomes, and viruses, within minutes. By enabling accurate measurement, impurity separation, and aggregation detection, Imessa's technology supports the advancement of more effective and affordable nanomedicine. The platform facilitates the analysis of lipid nanoparticles at various developmental stages and aids in evaluating product shelf life.
Target Audience
The primary customers are manufacturers and researchers in the nanomedicine sector who require precise and rapid characterization of nanoparticle formulations.
Features
- Nanoparticle separation and sizing technology for polydispersed samples
- Rapid analysis of lipid nanoparticles, liposomes, viruses, plasma proteins, and engineered nanoparticles
- Precise measurement of size distribution
- Capability to separate nanoparticles from impurities and aggregates
- Detection of nanoparticle aggregation
- Tools for evaluating product shelf life